Brief: Ryvu Therapeutics FY Net Loss At 101.2 Mln Zlotys
20/03/2026 06:16
March 20 (Reuters) - Ryvu Therapeutics RVU.WA: REPORTED ON THURSDAY FY NET LOSS AT 101.2 MLN ZLOTYS FY OPERATING REVENUE AT 87.7 MLN ZLOTYS FY OPERATING LOSS 107.6 MLN ZLOTYS Source text for Workspace: nEMBzSCja Further company coverage: RVU.WA (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Ryvu Therapeutics SA
See all newsBrief: Ryvu Therapeutics Signs Grant Agreement For Panacea-Novo Project With The National Center For Research And Development
Brief: Ryvu Therapeutics Q2 Net Loss 13.1 Million Zlotys
Brief: Ryvu Therapeutics "Dualis" Project Recommended For 22.2 Mln Zloty Subsidy
Brief: Ryvu Therapeutics Launches Early Clinical Development Services Business For Biotech And Pharma In Europe
Brief: Ryvu Therapeutics Says Panacea-Novo Project Recommended For Funding Of 106.7 Mln Zlotys